COA verifiedTirzepatide
10 mg · lyophilized powder
A dual GIP / GLP-1 receptor agonist studied in metabolic research.
Free shipping over $300 · ships Mon–Wed on ice
- Purity99.99%
- OriginSynthesized in the USA
- DocumentationThird-party COA included
- CAS number2023788-19-2
- Molecular formulaC225H348N48O68
- Molecular weight4813.5 g/mol
For research use only. All products sold by KelViva are intended exclusively for laboratory and educational research. They are not for human or veterinary consumption, medical treatment, or diagnostic use.
Specifications and the paperwork
Specifications & Documentation
| Compound | Tirzepatide |
|---|---|
| Strength | 10 mg |
| CAS Number | 2023788-19-2 |
| Molecular Formula | C225H348N48O68 |
| Molecular Weight | 4813.5 g/mol |
| Form | Lyophilized powder |
| Purity | 99.99% (HPLC / MS verified) |
| Grade | Research use only |
Tirzepatide for Incretin Receptor Research
Tirzepatide is a 39-amino-acid synthetic peptide engineered from the GIP sequence with a C20 fatty-diacid moiety. It activates both the glucose-dependent insulinotropic polypeptide (GIP) receptor and the GLP-1 receptor, making it a reference compound for dual-incretin signaling studies in vitro and in animal models.
KelViva supplies tirzepatide as a lyophilized powder, verified by independent third-party testing at or above 99% purity.
Specifications
- Molecular Formula: C225H348N48O68
- Molecular Weight: 4813.5 g/mol
- CAS: 2023788-19-2
- Form: Lyophilized powder, 10mg per vial
- Purity: 99.99% (HPLC, third-party verified)
For research use only. Not for human or veterinary use.
